Plain-English translation of NCT06457438 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking at samples from people who are donating organs or cells to see if they carry hepatitis E virus. Right now, standard screening of organ and cell donors doesn't routinely test for this virus, even though it can affect transplant safety. By testing donor samples in this study, researchers hope to better understand how common hepatitis E is among donors and help improve screening practices.
Hepatitis E is a virus that can be passed through organ and cell transplants, but current guidelines don't require routine testing for it. This study exists to fill that gap by finding out how often this virus appears in donors and what that means for transplant safety.
If you are an organ or cell donor, your samples that are already being collected during the donation process will also be tested for hepatitis E virus as part of this study. There are no extra visits or procedures — the researchers will examine your existing samples to look for signs of the virus. This is a one-time testing of your donation samples.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Czechia
Enrollment target
~300 participants
Started
January 2022
Primary completion
December 2024
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiří Hynčica
University Hospital Ostrava